Видео

Join us for an engaging Community Conversation focused on PEDDLE, the Patient Engagement in Drug Development Leading Through Example working group that ensures patients' voices are at the center of clinical trial design for MASH. This session will spotlight how patient experiences and perspectives are driving the development of more effective and patient-friendly clinical trials. Discover how t...

In this Community Conversation, we delve into the findings of the Fatty Liver Foundation's 2024 State of Steatotic (Fatty) Liver Care in America survey, which captures the real-life experiences of adults living with steatotic liver disease. Join us as we explore the challenges patients face, from diagnosis to treatment, and how their lived experiences shape the future of liver health care. Lear...

Understanding liver diseases can be tricky, especially with all the changing medical terms. This webinar will help make sense of metabolic dysfunction-associated steatohepatitis (MASH) in people living with HIV. We will explain what MASH is, why it matters, and how it relates to your health journey with HIV. We will talk about how MASH develops, its clinical significance, and how it affects dia...

This video covers how to use The Wellness League's Search Tool to find free and low-cost resources near you.

Join us for a captivating Community Conversation as we unveil the Fatty Liver Foundation's groundbreaking AI Fatty Liver Risk Stratification Tool. Developed in collaboration with Array Insights, this web-based tool uses cutting-edge machine learning to provide real-time risk assessment for liver disease. Learn how this tool has the potential to revolutionize fatty liver disease diagnosis and ma...

Join us for an enlightening Community Conversation as we discuss why doctors and experts are moving away from terms like NAFLD and NASH, and using new terms such as SLD, MASLD, MASH, and MetALD. This is not just a name change; it is a transformative approach to liver disease that aims to be more inclusive, patient-centric, and destigmatizing for individuals like you. Whether you are living with...

Navigating the world of fatty liver disease can be confusing, especially with changing medical terms and classifications. This webinar aims to demystify the new nomenclature for NAFLD (Non-Alcoholic Fatty Liver Disease) and NASH (Non-Alcoholic Steatohepatitis), providing you with a clear understanding of what these terms mean and how they relate to your health journey. We will explore the evolu...

Fatty Liver Foundation and Array Insights discuss the future of artificial intelligence (AI) in healthcare.

The Wellness League is a community focused, peer-driven platform that delivers non-clinical interventions to address social determinants of health and reduce disparities and inequities including holistic health education, liver health screening, linkage to clinical trials and care, and wellness navigation. Join Wayne Eskridge, a cirrhosis patient and CEO/Co-Founder of the Fatty Liver Foundation...

Diana - NAFLD in Hispanics Latinos in the US - GoFundMe

Overall GoFundMe Video

Tiffany - NAFLD Risk to Food Insecure Adults - GoFundMe Video

How the Fatty Liver Foundation is Innovating to Accelerate Personalized Medicine Research This FLF and Sano Genetics partnership aims to close the knowledge gap on hereditary risk factors within NAFLD/NASH patient community by offering home-based genetic testing with linkage to personalized opportunities for individuals to participate in NAFLD/NASH medical research and clinical trials. Speakers...

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease and rapidly becoming the leading cause of liver cancer and liver transplantation in the United States and other industrialized countries. NAFLD not only affects the liver but is also a multi-organ disease with increased risk of type 2 diabetes, cardiovascular and kidney diseases. Launched in June 2018, t...

FDA Patient Panel - Terri's Contribution

FDA Patient Panel - Wayne's Contribution

Wellness Webinar Series | Part-Three (Wellness and Living with NAFLD/NASH: Patient Panel)

Wellness Webinar Series | Part-Two (Non-Invasive Tests for Diagnosis and Monitoring)

Non-invasive Screening and Genomics in NAFLD with Sano Genetics

Reviving Fatty Livers (CGTN Feature)

Wellness Webinar Series | Part-One (COVID-19 Vaccines and Liver Disease)

Fatty Liver Foundation and Madrigal Pharmaceuticals Webconference (Part 2: Advice for New Patients)

Fatty Liver Foundation and Madrigal Pharmaceuticals Webconference (Part 3: After Diagnosis)

Fatty Liver Foundation and Madrigal Pharmaceuticals Webconference (Part 1: Wayne's Journey and FLF)

FLF LIVER Webinar Series | Part-Four (2020 In Review Interactive Q&A Panel Discussion)

4th Annual NASH Summit: Patient & Caregiver Fireside Chat

4th Annual NASH Summit Presentation: SUNN Study (Screening for Undiagnosed NAFLD & NASH)

helio interview AASLD

AASLD Patient Advocate Video Wayne, Rosemary & Tony v5 mp4